Literature DB >> 16032782

Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells.

Niramol Savaraj1, Yingjie Wei, Hitoshi Unate, Pei-Man Liu, C J Wu, Medhi Wangpaichitr, Diran Xia, Hong-Ji Xu, Shi-Xu Hu, M Tien Kuo.   

Abstract

It has been implicated that reactive oxygen species (ROS) play important roles in modulating tumor progression. However, the mechanisms by which redox-regulated tumor progression are largely unknown. We previously demonstrated that reduced intracellular redox conditions could be achieved in stably transfected small cell lung cancer cells with gamma-glutamylcysteine synthetase (gamma-GCSh) cDNA which encodes a rate-limiting enzyme in the biosynthesis of glutathione (GSH), a major physiological redox regulator. In the present study, using DNA microarray analyses, we compared the expression profiles between the gamma-GCSh-transfected cells and their nontransfected counterpart. We observed downregulation of several matrix metalloproteinases (MMPs), i.e., MMPI and MMP3, and MMP10 in the transfected cells. Dot blot and Northern blot hybridizations confirmed that, among the 18 MMP gene family members and four tissue inhibitors of matrix metalloprotein family (TIMP) analyzed, the expression levels of these three MMPs were consistently reduced. Transiently increased gamma-GCSh expression using tetracycline-inducible gamma-GCSh adenoviral expression system also showed down-regulation of MMP3 and MMP10, but not MMP1. Our results demonstrated that redox regulation of MMP1, MMP3 and MMP10 expression depend upon different modes of redox manipulation. These results bear implication that antioxidant modulation of antitumor progression may be contributed at least in part by the downregulation of a subset of metrix metalloproteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16032782     DOI: 10.1080/10715760400029694

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  8 in total

Review 1.  Redox metabolism and malignancy.

Authors:  Christina L Grek; Kenneth D Tew
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

2.  Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.

Authors:  Kyung Hee Lee; Jae Ryong Kim
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

3.  Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1.

Authors:  Helen H W Chen; Im-Sook Song; Anwar Hossain; Min-Koo Choi; Yoshiaki Yamane; Zheng D Liang; Jia Lu; Lily Y-H Wu; Zahid H Siddik; Leo W J Klomp; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

4.  Elevated GSH level increases cadmium resistance through down-regulation of Sp1-dependent expression of the cadmium transporter ZIP8.

Authors:  Isamu Aiba; Anwar Hossain; Macus Tien Kuo
Journal:  Mol Pharmacol       Date:  2008-06-12       Impact factor: 4.436

5.  NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.

Authors:  Suhrid Banskota; Sushil C Regmi; Jung-Ae Kim
Journal:  Mol Cancer       Date:  2015-06-27       Impact factor: 27.401

6.  Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation.

Authors:  Jorge González-Zamora; María Hernandez; Sergio Recalde; Jaione Bezunartea; Ana Montoliu; Valentina Bilbao-Malavé; Josune Orbe; José A Rodríguez; Sara Llorente-González; Patricia Fernández-Robredo; Alfredo García-Layana
Journal:  Biomedicines       Date:  2022-06-30

7.  Glutathione-S-transferase M1 regulation of diesel exhaust particle-induced pro-inflammatory mediator expression in normal human bronchial epithelial cells.

Authors:  Weidong Wu; David B Peden; Rob McConnell; Scott Fruin; David Diaz-Sanchez
Journal:  Part Fibre Toxicol       Date:  2012-08-06       Impact factor: 9.400

8.  Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.

Authors:  Wook Youn Kim; Ji-young Jang; Yoon Kyung Jeon; Doo Hyun Chung; Young Goo Kim; Chul-Woo Kim
Journal:  Exp Mol Med       Date:  2014-04-11       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.